UCB | Attività Correnti



Current Assets Cambiamento Data
Alcon AG USD 6.31B 10M 2024-12
Almirall EUR 693.24M 29.14M 2024-06
Amarin USD 650.22M 51.62M 2024-09
AstraZeneca USD 25.83B 1.67B 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Galapagos EUR 3.34B 219.98M 2024-12
Genmab DKK 27.85B 4.16B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
GRIFOLS EUR 5.73B 404.28M 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.93B 882M 2024-09
Novartis USD 29.7B 1.56B 2024-12
Orion EUR 1.02B 40.7M 2024-12
Recordati EUR 1.26B 10.61M 2024-09
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
UCB EUR 4.79B 1.47B 2024-12
Unibail Rodamco EUR 7.12B 550.2M 2024-12



UCB Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.